[Karl Note: Here is an excellent example of how a young man, studying first in China, then in the US, can get himself on the fast track to success and high recognition. All he has to do is figure out what some drug company, preferably one of the large ones, wants out of "research findings," and then deliver that. It is even possible that most of his scientific reports are honest, but here is someone who has sold his soul to the devil, in the current case, Pfizer, going to China on their nickel to get the research results that THEY wanted. And so does Tulane University serve the public trust!]
Jiang He
Dr.
He is an associate professor in the Department of
Epidemiology at the Tulane University School of Public
Health and Tropical Medicine. Dr. He received his medical
degree and completed his residency in internal medicine
at the Jiangxi Medical College, the People's Republic of
China. He then went to the Peking Union Medical College
and Chinese Academy of Medical Sciences to study a doctor
of medical science degree in epidemiology. Dr. He came to
US in 1989 and completed his PhD and postdoctoral
training in the Department of Epidemiology at the Johns
Hopkins School of Hygiene and Public Health.
In 1996, Dr. He became a core faculty member at the Welch Center for Prevention, Epidemiology, and Clinical Research and an instructor in the Department of Epidemiology, the Johns Hopkins University School of Hygiene and Public Health. In 1997, Dr. He joined the faculty of the Department of Biostatistics and Epidemiology at the Tulane University School of Public Health and Tropical Medicine as an assistant professor. In 2000, he was promoted to associate professor with tenure.
Dr. He has been twice nominated as finalist for the Jeremiah Stamler Research Award for New Investigators by the American Heart Association, Council on Epidemiology and Prevention. Dr. He received the "People to Watch" award from New Orleans Magazine in 1999 and the Tulane University President’s Award for Excellence in Research in 2000.
Dr. He's research has been focus on the etiology and prevention of cardiovascular disease, including hypertension, diabetes, dyslipidemia, coronary heart disease, stroke, congestive heart failure, and end-stage renal disease. Dr. He has been Principal Investigators for several research projects sponsored by the National Institutes of Health and American Heart Association. He has published more than 60 scientific research papers.
Research Interests
Selected Publications
General Clinical Research Center
Tulane - Charity Hospital - LSU
[Karl Note: Here is a research study PROPOSAL showing that Dr. Jiang appears to be investigating whether so-called "alternative" methods of lowering blood pressure will work. This study cannot show anything but a negative result -- otherwise Dr. Jiang would not be promoted. But, now that he has this study under his belt, he looks "balanced" when it comes to studying DRUGS to accomplish the same thing! Thus the evil starts very early in some researcher's life, and even HE may think he is pursuing some noble cause!]
|
INSTITUTION & LOCATION
|
DEGREE
|
YEAR(S)
|
FIELD OF STUDY
|
|
| Jiangxi Medical College - Jiangxi, PR China |
MD
|
1982
|
Medicine
|
|
| Peking Union Medical College - Beijing, PR China |
DMedSc
|
1994
|
Epidemiology
|
|
| Johns Hopkins University School of Hygiene and Public Health - Baltimore, MA |
PhD
|
1996
|
Epidemiology
|
Protocol(s):
| Randomized Controlled Trial of Dietary Fiber and Blood Pressure (97-0037). |
| SPECIFIC AIMS The primary aims of the proposed trial are to test whether, over 6 months of supplementation, 10 grams of soluble fiber ( -glucan extracted from oat bran) a day will decrease systolic (SBP) and diastolic (DBP) blood pressure in 200 participants with untreated high normal BP (SBP: 130 to 139 mm Hg; or DBP: 80 to 89 mm Hg). The proposed trial is designed to provide greater than 80% statistical power to detect a 3.0 mm Hg reduction in SBP and a 2.0 mm Hg reduction in DBP at a significance level of 0.05 using a two-tailed test. Additional aims are to test whether dietary fiber supplementation will reduce: -Serum glucose and insulin levels; -Serum total- and LDL-cholesterol, and triglyceride levels; -Body weight. The impact of change in serum levels of insulin, glucose and lipids, and body weight on the possible reduction in BP will be explored. The proposed trial will provide insight into the mechanisms of the BP-lowering effect of dietary fiber. |
|
[Karl Note: See the plan developing. Here in 1996 Dr. Jiang is establishing the politically correct data, based on "independent research" that when rural Chinese move to the big city, where they eat the foods condemned by the American Heart Association, they get high cholesterol. This man has planned well his success in academia -- the drug companies have followed his career with great interest, guiding a bit, here and there, as necessary. As long as he stays on THEIR path, he will succeed.]
|
On Research:
|
Isolated in rural China,
the ethnic Yi don't suffer from cardiovascular
diseases. But when they move to the city, leaving
their traditional life styles and diets at home in
exchange for life in the faster lane where higher fat
diets and less physical activity are the rule, they
often develop higher blood pressure and hypertension
and may become overweight.
According to School of Public Health researcher Jiang He, these conclusions from a two-year study of Yi farmers and migrants have implications for making life-style dietary changes to lowering cardiovascular disease risks. The study was jointly conducted by researchers from the Welch Center for Prevention, Epidemiology and Clinical Research at the School of Public Health and researchers in the People's Republic of China. The study, which will appear in the Nov. 1 issue of the American Journal of Epidemiology, suggests that diets higher in fat that increase serum lipid levels--high cholesterol--when coupled with less physical activity, are leading the urban Yi not only down the path toward greater sophistication, but to cardiovascular diseases as well. "In the 1950s, Yi farmers, who live on potatoes, rice, corn, oats and buckwheat, began to migrate to Xichang City," Jiang He said. "At home, the Yi only eat meat for celebrations, for weddings and funerals. Animal and vegetable fat are not used for cooking." With an early interest in the health and diet of remote peoples, Jiang He began his research on the Yi when studying at Peking Union Medical College with Guan-Qing He, a co-researcher in this study and a 1940s alumnus of the School of Public Health. After coming to the school, Jiang He went back to the isolated Yi villages, 3,000 meters above sea level, to gather more data before making the connection to urban, migrant Yi. Backpacking into the mountainous villages, Jiang He took blood pressures and drew blood to measure serum total and high density lipoprotein cholesterol and serum triglyceride levels. After testing more than 500 Yi farmers with the help of local physicians, similar tests were conducted with 300 migrants in their new urban setting. The data on the urban Yi, of Mongolian descent, were then compared with ethnic Han peoples, non-Mongolians who are the most prominent ethnic group in China and live in the same city. Information on age, cigarette smoking, alcohol consumption, nutrition and physical activity was obtained by questionnaire. Across the board, Yi migrants had higher blood pressure, higher cholesterol and engaged in less physical activity than their stay-at-home relatives. As a result, their cholesterol and other health profiles were much more like those of their new urban neighbors, the Han. According to Jiang He, the data tend to dispel the notion of a strong genetic link to higher cholesterol in favor of an environmental, life-style correlation. "This study gave us an unusual opportunity to compare the effects of environment and ethnic heritage on serum lipid levels," said Jiang He. "Most people talk about high cholesterol as a genetic problem, running in families. This study confirmed that dietary fat and cholesterol intake--life-style eating patterns--are important in high cholesterol. The diets of the migrants were higher in fats and lower in fiber. Their cigarette smoking, alcohol consumption and lack of physical activity suggests that their new life-styles can lead to hyperlipidemia and cardiovascular diseases." Looking at the data on cardiovascular risk and serum cholesterol levels, the cholesterol-related life-style changes put the Yi migrants at a 76 percent greater chance of developing cardiovascular illness than their relatives at home, according to Michael J. Klag, also of The Welsh Center and co-author of the study. In earlier studies, Jiang He and Klag looked at the oat and buckwheat diet of the rural Yi and found that their diet correlated with their low prevalence of cardiovascular diseases. "Because oats and buckwheat are associated with low serum cholesterol, these foods may be useful in life-style modifications to reduce or prevent cardiovascular diseases," said Jiang He. "The lives of the rural Yi are changing because they are more in touch with the urban areas. I would like to go back to see how changes are affecting their diet and health," Jiang He added. |
Welcome to
He Jiang's Homepage
hahaha.............
you are
visitor from 09/17/99
| My favorite things ...... |
| Personal files |
share with my favorite book
(quick read) 
Friendly
links:
Jiang
Ping's homepage
Wu
Xinyu's homepage
Xue
Liang's homepage
Wei
Zhou's homepage
Yi
Lin's homepage
[Karl Note: When a young professor gets something published in JAMA, you know he is on his way! Unfortunately he is on the wrong way!]
       |
 |
|||||||||||
         |
||||||||||||
|
     |
|||||||||||
|
||||||||||||
  |
||||||||||||
|
|
|
  See Related:
|
|
|
|
|
Dietary Sodium Intake and Subsequent Risk of Cardiovascular Disease in Overweight Adults  Jiang
He, MD, PhD; Lorraine G. Ogden, MS; Suma Vupputuri,
MPH; Lydia A. Bazzano, BS; Catherine Loria, PhD, MS;
Paul K. Whelton, MD, MSc Context Dietary sodium is positively associated with blood pressure, and ecological and animal studies both have suggested that high dietary sodium intake increases stroke mortality. Objective To examine the risk of cardiovascular disease associated with dietary sodium intake in overweight and nonoverweight persons. Design Prospective cohort study. Setting The first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, conducted in 1982-1984, 1986, 1987, and 1992. Participants Of those aged 25 to 74 years when the survey was conducted in 1971-1975 (14,407 participants), a total of 2688 overweight and 6797 nonoverweight persons were included in the analysis. Main Outcome Measures Dietary sodium and energy intake were estimated at baseline using a single 24-hour dietary recall method. Incidence and mortality data for cardiovascular disease were obtained from medical records and death certificates. Results For overweight and nonoverweight persons, over an average of 19 years of follow-up, the total number of documented cases were as follows: 680 stroke events (210 fatal), 1727 coronary heart disease events (614 fatal), 895 cardiovascular disease deaths, and 2486 deaths from all causes. Among overweight persons with an average energy intake of 7452 kJ, a 100 mmol higher sodium intake was associated with a 32% increase (relative risk [RR], 1.32; 95% confidence interval [CI], 1.07-1.64; P = .01) in stroke incidence, 89% increase (RR, 1.89; 95% CI, 1.31-2.74; P<.001) in stroke mortality, 44% increase (RR, 1.44; 95% CI, 1.14-1.81; P = .002) in coronary heart disease mortality, 61% increase (RR, 1.61; 95% CI, 1.32-1.96; P<.001) in cardiovascular disease mortality, and 39% increase (RR, 1.39; 95% CI, 1.23-1.58; P<.001) in mortality from all causes. Dietary sodium intake was not significantly associated with cardiovascular disease risk in nonoverweight persons. Conclusions Our analysis indicates that high sodium intake is strongly and independently associated with an increased risk of cardiovascular disease and all-cause mortality in overweight persons. [Karl Note: I would not disagree with this finding, sodium is generally the substance you get when you drink sodas, and they are the bane of the American diet. Dr. Jiang is publishing the stuff that will make him seem one of the good guys, but it has been well known for years that soda was a bad item in your diet. No, the real reason for this research is to make Dr. Jiang appear to be one of the good guys. When you get down to the bottom line, the drug companies know that people will continue to drink soft drinks, with lots of sodium, and whether THAT has anything to do with heart disease or not is beside the point. The real point is that people will need the cholesterol-lowering drugs that are coming along on Dr. Jiang's future research path -- this article was published in 1999. It was in April 2002 that Dr. Jiang finally got into the main track of supporting the drug companies -- his "alternative health" credentials having been established. Click here for the April 2002 study results -- Dr. Jiang is now ready to support Lipitor and other such drugs -- directly!] JAMA. 1999;282:2027-2034
View Full Text Funding/Support: This study was supported by grant R03 HL61954, and in part by grant R01 HL60300 from the National Heart, Lung, and Blood Institute and a career development grant to Dr He from the Office of the Dean, Tulane University School of Public Health and Tropical Medicine. The NHANES I Epidemiologic Follow-up Study has been developed and funded by the National Center for Health Statistics; National Institute on Aging; National Cancer Institute; National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institute of Mental Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institute of Neurological and Communicative Disorders and Stroke; Centers for Disease Control and Prevention; and US Department of Agriculture.
|
|
|
|
|
|
 |
|
|
|
|
© 1999 American Medical Association. All rights reserved. |
|
|
|
|
||||
|
|
|
|
||
   |
 |
|||
|
|
||||
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.
